Table 2.
Applications of MALDI-TOF MS for specific antimicrobial resistance (AMR) detection.
| Organism | Antibiotic | Year (Reference) |
|---|---|---|
| E. coli | Polymyxins | 2018 [122] |
| E. coli | Colistin | 2019 [123] |
|
E. coli
Klebsiella pneumoniae |
Beta-lactams (ESBL-producing isolates) | 2019 [124] |
|
Staphylococcus aureus
S. intermedius S. pseudintermedius |
Novobiocin Polymyxin B Acriflavine |
2019 [125] |
| S. aureus | Methicillin | 2019 [126] |
| Candida auris | Echinocandins | 2019 [127] |
|
K. pneumoniae
Bacteroides fragilis S. aureus |
Carbapenems (carbapenemase-producing isolates) Methicillin |
2019 [128] |
| Enterobacteriaceae | Carbapenems (carbapenemase-producing isolates) | 2019 [129] |
| Enterobacteriaceae | Carbapenem | 2019 [130] |
| Pseudomonas aeruginosa | Beta-lactams (MBL) | 2019 [131] |
| Enterococcus faecium | Vancomycin | 2019 [132] |
| K. pneumoniae | Carbapenems (carbapenemase-producing isolates) | 2019 [133] |
| Acinetobacter baumannii | Colistin | 2020 [134] |
|
E. coli
K. pneumoniae |
Cefotaxime Meropenem, Ciprofloxacin |
2020 [135] |
|
S. aureus Enterococcus species E. coli K. pneumoniae |
Oxacillin (methicillin) Vancomycin Ceftriaxone Meropenem |
2020 [136] |
| Enterobacterales | Imipenem/Relebactam | 2020 [137] |
| S. aureus | Methicillin | 2020 [138] |